Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool March 2, 2004 Wherrett & Yelovich	Commercializing Nanotechnology This article gives you an overview of the three "industries" -- nanomaterials, nanobiotechnology, and nanoelectronics -- that will most use the technology, and some of the companies poised to benefit from the emerging science.
The Motley Fool August 30, 2004 Wherrett & Yelovich	The Players and Pretenders of Nanotech Some companies are positioning themselves to make big profits in tomorrow's small tech. Here are some investment opportunities in the nanotech world.
The Motley Fool January 27, 2005 Wherrett & Yelovich	Billion-Dollar Markets Nanoparticulates offer golden opportunities for investors... if you know where to look.
The Motley Fool February 24, 2004 Wherrett & Yelovich	Profiting From Nanotechnology Can you profit from this technology? An overview of what the science is and where opportunity may lie for investors.
The Motley Fool October 19, 2004 Wherrett & Yelovich	Attack of the Nanobots! You can fear nanotechnology, or you can profit from it.
The Motley Fool May 16, 2005 Carl Wherrett	The Next Tech Revolution At the smallest scale known to man lies the future of civilization. But what of investors? Should our portfolios take notice of this emerging, but as yet commercially unproven, technology?
The Motley Fool January 6, 2006 Jack Uldrich	2005 Gave Nanotech Investors Plenty to Chew On For investors who have been holding off investing in nanotechnology because they thought there was more "sizzle" than "steak," here are some developments that offer plenty to chew on.
The Motley Fool August 4, 2005 Jack Uldrich	3M: Great at the Little Things The maker of Scotch Tape, Post-It Notes, and Thinsulate is also a nanotech powerhouse well-positioned to employ the emerging science of the small across its entire line of diversified products. Investors, take note.
The Motley Fool November 17, 2004 Wherrett & Yelovich	Intel's Hare and AMD's Tortoise The chip making rivals race to be the fastest and smallest in nanotechnology. Investors take note.
IndustryWeek August 1, 2005 John Teresko	Two Steps Forward, One Back? Leaders such as Motorola and IBM have embraced nanomaterials, but by spending less on R&D, the U.S. manufacturing sector could be stumbling in the race for more innovative products.
The Motley Fool November 29, 2005 Jack Uldrich	IBM: A Very Small Bright Light Big Blue's latest announcement could lead to a myriad of uses in computers, telecommunications, and lighting. Investors, take note.
The Motley Fool August 27, 2007 Jack Uldrich	Nano's Big Numbers Nanotechnology isn't quite doubling every year, but it's still making rapid progress. Come 2015, the field's overall value might surprise a great many people. If you want to take advantage of this opportunity, start familiarizing yourself with the industry now.
The Motley Fool October 28, 2005 Jack Uldrich	A New Nanotech Fund The PowerShares fund tries to make it easier to invest in nanotech. But the choice of companies could have been better.
The Motley Fool February 3, 2010 Anders Bylund	Ride the Space Elevator to Riches! Harris & Harris and other nanotech specialists could ride their own space elevator in the next couple of years.
The Motley Fool July 7, 2004 W.D. Crotty	GE Flexes Its Nanotech Muscle Breakthrough signals enhanced electronics, and bodes well for dividends.
The Motley Fool February 16, 2010 Brian Orelli	For Blockbuster Cancer Drugs, Approvals Are the Easy Part Don't get too excited. As an investor, you can lower your risk by investing in cancer drug companies after a clinical trial success but before an FDA approval, but you'll also reduce your reward.
Military & Aerospace Electronics September 2004 John McHale	Nanotechnology: The Revolution Has Begun Nanotechnology, heavily researched and funded across the globe, promises to revolutionize many applications in space flight and communications. The advanced miniaturization concepts will proliferate across many industries in addition to defense and aerospace.
The Motley Fool August 8, 2006 Jack Uldrich	Beware the Nano Lawyers Growing confusion over nanotechnology-related patents could snare investors. Investors need to consider the strength of a company's intellectual property (IP) portfolio.
Pharmaceutical Executive October 1, 2006 Jason McKinnie	Smaller is Better Everybody has heard about using nanotechnology in drug delivery, but not many people - even specialists in drug development - know quite where the new technology fits in.
The Motley Fool April 21, 2005 Jack Uldrich	Something Small, Something Blue Feeling blue over Big Blue? IBM investors should think small and think long. IBM's stock has taken a large hit in April. Investors interested in Big Blue's long-term potential are encouraged to look at the company's strategy for nanotechnology.
The Motley Fool December 23, 2004 Wherrett & Yelovich	The Building of a Market Thank you for flying, nano enthusiasts. Now hold on. From an investment perspective, the report of shoddy deliveries reminds us that nanofakers are still out there, making promises.
The Motley Fool May 23, 2005 Carl Wherrett	Goliaths Face a Nano Challenger Nano-Proprietary's patents threaten the display plans of some tech giants. Investors in Nano-Proprietary should be increasingly excited about its prospects
The Motley Fool March 23, 2011 Brian Orelli	Eli Lilly: Great Plan, Poor Execution Eli Lilly shuns large mergers, but hasn't produced drugs on its own.
The Motley Fool October 29, 2004 W.D. Crotty	Future Looking Up for Flamel As the nanotech/biotech company earns a profit -- keep an eye on two drugs in phase 3 trials.
BusinessWeek April 18, 2005 Adam Aston	The Coming Chip Revolution Facing the limits of silicon, scientists are turning to carbon nanotubes. But even with a reliable supply of tubes, scaling up production to supply a vast global industry will take years.
The Motley Fool June 15, 2005 Charly Travers	Flamel's CEO Must Go Because the biotech firm has disappointed, investors have understandably not rewarded its lousy results. Flamel's shareholders must vote to remove a management road block to the company's success.
The Motley Fool January 9, 2006 Jack Uldrich	More Big 2005 Nanotech News A recap roundup of big news in tiny tech continues: When Fortune 500 companies weren't partnering with or acquiring promising nanotechnology startups, many of them were investing heavily in their own nanotechnology-related research and development. Investors, take note.
The Motley Fool November 6, 2006 Jack Uldrich	TINY Investment Inches Closer to Payoff Carbon nanotubes move into semiconductor production fabs. Until more details are forthcoming, investors are cautioned against getting too excited.
PC Magazine July 13, 2004 Jim Akin	Nanotechnology Size Matters Incubating inside this tiny world are some big ideas that could improve everything from manufacturing to health care.
The Motley Fool December 31, 2010 Brian Orelli	2010 FDA Approvals and a Look Ahead Recent history can help us handicap FDA decisions.
The Motley Fool July 30, 2010 Brian Orelli	A Faster Pathway to Drug Approvals A thinktank called the Pacific Research Institute has proposed letting drugs approved by the European Medicines Authority onto the market in the U.S. before the Food and Drug Administration has approved the drugs.
The Motley Fool September 27, 2005 Jack Uldrich	A Ray of Hope for Flamel? New hepatitis C treatment offers a ray of hope to the ailing nanotech company. Unfortunately, this news does not guarantee sunnier days ahead.
The Motley Fool March 4, 2005 Rich Duprey	Flamel Flames Out Again Nanotech regains rights to herpes treatment as partnership with pharma Biovail fails.
Bio-IT World March 8, 2005 Salvatore Salamone	Nano Poised for Liftoff First 'nano' technologies yield fruit in the biomedical lab and clinic with the promise of more to come.
The Motley Fool May 12, 2005 Jack Uldrich	Risk in Carbon Nanotubes? Nanotech's "wonder" materials might also carry a substantial downside. Until the questions surrounding carbon nanotubes can be adequately answered, investors are encouraged to temper their enthusiasm
Reason December 2003 Ronald Bailey	The Smaller the Better The limitless promise of nanotechnology -- and the growing peril of a moratorium.
The Motley Fool August 18, 2004 W.D. Crotty	MRAM: The Holy Grail of Memory NVE Corporation investors are excited by the company's "spintronics" nanotechnology used for Magnetoresistive Random Access Memory (MRAM.) The stock rocketed up more than $9 a share on news it was awarded a key patent.
Entrepreneur May 2008 Andrea Cooper	Small Wonders In the world of nanotechnology, good things come in really small packages.
The Motley Fool December 28, 2004 Wherrett & Yelovich	Nano Firms Tie the Knot The merger of Carbon Nanotechnologies Inc. (CNI) and C Sixty, along with an expanding customer base, makes CNI an even more attractive IPO. Will 2005 be the year carbon nanotubes are introduced to the public?
CIO January 1, 2003 Julie Hanson	The Next Little Thing Perhaps the Next Big Thing on the horizon, nanotechnology is the science of manipulating materials on an atomic or molecular scale.
IndustryWeek October 20, 2010	Nanotechnology: Beyond the Hype Nanotechnology can make things lighter, stronger or more efficient, but can it really revolutionize industries such as medicine or energy?
The Motley Fool March 8, 2010 Brian Orelli	Really? A 59% Share Price Jump for That? Justified or not, InterMune skyrockets ahead of an FDA panel meeting.
InternetNews January 16, 2004 Susan Kuchinskas	Big Memory, Itty-Bitty Chips Intel's experiments with nanotechnology grow, as it collaborates with Nanosys on future chips.
The Motley Fool March 17, 2005 Dan Bloom	Ready for Some Carbon Nanotubing? Carbon nanotubes are going to show up in all sorts of high tech devices. Be ready for them.
The Motley Fool May 7, 2004 Mark Chapman	Nano's Great Leap It's too soon to be pointing out "winners" in this industry, but with tangible products and, in some cases, actual profits, here are some true nano technology companies that are worth researching further.
The Motley Fool December 22, 2005 Jack Uldrich	DuPont: The Truth Helps Nanotech The company's honesty provides a long-term insurance policy for developments in this promising field. Will DuPont's openness be rewarded in the marketplace?
The Motley Fool April 21, 2005 Carl Wherrett	Universal Displays Its Potential The nano company sees its stock jump 30% after a deal with Samsung. The OLED market is in its infancy, but it's growing fast.
The Motley Fool September 20, 2004 Wherrett & Yelovich	Flamel Shot Down The company's nano product loses some of its shine. The stock fell more than 25% after Bristol-Myers Squibb pulled out of its partnership to develop Basulin.
The Motley Fool October 25, 2005 Jason Mac Gurn	Visualizing Value for Flamel Those interested in the long-term potential of this biotech's business should be searching for signs that its technological potential will evolve to provide value for shareholders.
The Motley Fool August 5, 2004 Rich Duprey	Nano Says No to IPO Citing "adverse market conditions" Nanosys, a Palo Alto-based nanotechnology start-up, pulled its IPO.